Epilepsy News

Five newer antiseizure medications approved since 2008 did not increase suicidality risk among people with epilepsy, according to results of a meta-analysis published in JAMA Neurology.

Surgery for mesial temporal lobe epilepsy correlated with a reduction in imaging-defined brain age, indicating that morphological brain changes related to accelerated aging may be reversible, according to a study published in Neurology.

Results from an analytical decision model demonstrated that short-term, 7-day prophylaxis “dominates” long-term therapy for seizure prophylaxis after spontaneous intracerebral hemorrhage.

Adrenocorticotropic hormone and oral steroids demonstrated superiority compared with non-standard therapy for the initial treatment of infantile spams in a prospective, multicenter observational cohort study published in Neurology.

Individuals with late-onset epilepsy experienced an increased risk for death compared with individuals without epilepsy, even after adjustment for comorbidities, according to findings published in Neurology.

Several factors, including pediatric ICU admission and multispecialty care, increased length of stay and costs at pediatric neurology hospitals, according to results of a retrospective review published in Journal of Child Neurology.

Patients with benzodiazepine-refractory convulsive status epilepticus who received a home medication vs. non-home medication did not differ in cessation of clinical seizures with improved consciousness by 60 minutes after drug initiation.

A survey of community neurologists demonstrated four primary themes associated with the impact of the COVID-19 pandemic in this group, specifically highlighting “the unusual environment” in which these providers practice.

Adults with epilepsy who initiated any osteoporosis drug therapy had a lower 3-year mortality risk compared with those who did not take a medication, according to study data published in Bone.

Youth with psychogenic nonepileptic seizures experienced an increased risk for numerous psychiatric disorders compared with those with epilepsy and healthy controls, according to results of a nationwide matched cohort study.